Has Michael Bateman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,683 in general payments to Michael Bateman, MD across 172 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Bateman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Bateman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Bateman, MD

Plastic and Reconstructive Surgery · Denver, CONPI 1871675314

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,149 of the $12,683 with a category attached, or 64.3%. It is spread thinly across 24 manufacturers, the largest accounting for just 19.2%. 2025 is the largest year on record at $4,204, 5.5 times the $761 reported in 2019.

$12,683in general payments, 2019–2025

Across 172 payments — averaging $73.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

RTI Surgical, Inc$2K
Musculoskeletal Transplant Foundation Inc.$2K
Axogen$2K
AbbVie$2K
Sientra, Inc.$1K
Shockwave Medical, Inc$707
plus $2K from 18 others

What the payments were for

Speaking & faculty fees$2,40019%
Travel & lodging$2,13417%
Food & beverage$8,14964%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
RTI Surgical, Inc	4	$2,430
Musculoskeletal Transplant Foundation Inc.	18	$2,405
Axogen	19	$2,240
AbbVie(2 entities)	65	$1,924
Sientra, Inc.	16	$1,140
Shockwave Medical, Inc	6	$707
Motiva USA, LLC	5	$460
Integra Lifesciences Corporation	11	$381
Mentor Worldwide LLC	7	$336
Stryker	2	$183
Surgalign Spine Technologies, Inc.	2	$61
Revance Therapeutics, Inc.	1	$59
Davol Inc.	2	$58
GSK	3	$45
Solventum Corporation	2	$39
Merz North America, Inc.	1	$37
Vertex	1	$32
TELA Bio, Inc.	1	$27
Galderma Laboratories, L.p.	1	$27
Innovation Technologies Inc	1	$25
Pacira Pharmaceuticals Incorporated	1	$19
Johnson & Johnson	1	$19
Conmed Corporation	1	$15
Lemaitre Vascular, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CORTIVA ALLOGRAFT DERMIS$2,400
AVANCE NERVE GRAFT$1,850
AxoGuard Nerve Connector$1,530
AxoGuard Nerve Protector$1,530
SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$888
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$477
ALLODERM$448
Motiva Implant Matrix$414
INTEGRA$286
NATRELLE$275
NATRELLE SALINE-FILLED BREAST IMPLANTS$248
AXOGUARD HA+ NERVE PROTECTOR$217
AxoGuard Nerve Cap$217
MENTOR MemoryGel Resterilizable Gel Sizer$174
OMNIGRAFT$143
SURGIMEND$143
INTEGRA DERMAL REGENERATION TEMPLATE$143
STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$140
SPY TECHNOLOGY$139

How this compares

$12,683 in reported general payments places this provider in the 80th percentile of 54 plastic and reconstructive surgery providers in Colorado.

See all plastic and reconstructive surgery providers in Colorado →

Medicare billing

Part B allowed, 2024

$28,032

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	23	$313

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Denver

Jarom GilstrapDenver$28K
Justin CohenDenver$6K
Corrine WongDenver$5K
Joyce AycockDenver$4K
Leela MundraDenver$2K
Christine RodgersDenver$2K
Manish ShahDenver$2K
Rebekah ZaluzecDenver$503
John Cochran JrDenver$392
William BrownDenver$109

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →